PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE +...

PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE + OXALIPLATIN) VERSUS FOLFOX-4 (5-FU/LV + OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

G Prolla, LG Borges, E Santos
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(11)71988-x
File:
PDF, 99 KB
english, 2010
Conversion to is in progress
Conversion to is failed